Intranasal Immunization with Toxoplasma gondii SAG1 Induces Protective Cells into Both NALT and GALT Compartments

ABSTRACT Intranasal (i.n.) immunization with the SAG1 protein ofToxoplasma gondii plus cholera toxin (CT) provides protective immunity. The aim of this study was to analyze the cellular activation of several mucosal compartments after i.n. immunization. Cervical and mesenteric lymph node (CLN and MLN, respectively) lymphoid cell and intraepithelial lymphocyte (IEL) passive transfer experiments were performed with CBA/J mice immunized i.n. with SAG1 plus CT. CLN and MLN cells and IEL isolated 42 days after immunization conferred protective immunity on naive recipient mice challenged with strain 76KT. gondii, as assessed by the reduction in the number of brain cysts. There were proliferative specific responses in nose-associated lymphoid tissue and the CLN and MLN cells from mice immunized with SAG1 plus CT, but no cytokine was detectable. Thus, protective immunity is associated with a specific cellular response in the nasal and mesenteric compartments after i.n. immunization.

[1]  H. Debbabi,et al.  Intraepithelial lymphocytes traffic to the intestine and enhance resistance to Toxoplasma gondii oral infection. , 1999, Journal of immunology.

[2]  D. Bout,et al.  Gut-derived intraepithelial lymphocytes induce long term immunity against Toxoplasma gondii. , 1998, Journal of immunology.

[3]  E. Denkers,et al.  Regulation and Function of T-Cell-Mediated Immunity during Toxoplasma gondii Infection , 1998, Clinical Microbiology Reviews.

[4]  O’Hagan,et al.  Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses , 1998, Immunology.

[5]  I. Corthésy-Theulaz,et al.  Mice Are Protected from Helicobacter pylori Infection by Nasal Immunization with AttenuatedSalmonella typhimurium phoPc Expressing Urease A and B Subunits , 1998, Infection and Immunity.

[6]  F. Carbone,et al.  Activation and migration of CD8 T cells in the intestinal mucosa. , 1997, Journal of immunology.

[7]  E. Butcher,et al.  Homing of naive and memory T lymphocyte subsets to Peyer's patches, lymph nodes, and spleen. , 1997, Journal of immunology.

[8]  R. Roden,et al.  Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice , 1997, Infection and immunity.

[9]  D. Bout,et al.  Adoptive transfer of gut intraepithelial lymphocytes protects against murine infection with Toxoplasma gondii. , 1997, Journal of immunology.

[10]  M. Russell,et al.  Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system , 1997, Immunologic research.

[11]  M. Russell,et al.  Induction of antibody‐secreting cells and T‐helper and memory cells in murine nasal lymphoid tissue , 1996, Immunology.

[12]  D. Bout,et al.  Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection , 1996, Infection and immunity.

[13]  K. Rosenthal,et al.  Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. , 1995, Vaccine.

[14]  D. Bout,et al.  Toxoplasma gondii oral infection induces specific cytotoxic CD8 alpha/beta+ Thy-1+ gut intraepithelial lymphocytes, lytic for parasite-infected enterocytes. , 1994, Journal of immunology.

[15]  E. Butcher,et al.  Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo. , 1994, Journal of immunology.

[16]  D. Bout,et al.  Oral immunization with Toxoplasma gondii antigens in association with cholera toxin induces enhanced protective and cell-mediated immunity in C57BL/6 mice , 1993, Infection and immunity.

[17]  D. Bout,et al.  Mucosal and systemic cellular immune responses induced by Toxoplasma gondii antigens in cyst orally infected mice. , 1993, Immunology.

[18]  M. Russell,et al.  Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit , 1993, Infection and immunity.

[19]  C. Czerkinsky,et al.  Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. , 1993, Vaccine.

[20]  J. Kraehenbuhl,et al.  Molecular and cellular basis of immune protection of mucosal surfaces. , 1992, Physiological reviews.

[21]  J. Mcghee,et al.  The mucosal immune system: from fundamental concepts to vaccine development. , 1992, Vaccine.

[22]  B. Malissen,et al.  Two gut intraepithelial CD8+ lymphocyte populations with different T cell receptors: a role for the gut epithelium in T cell differentiation , 1991, The Journal of experimental medicine.

[23]  A. Sher,et al.  Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. , 1991, Journal of immunology.

[24]  J. Dubremetz,et al.  Antibody responses to Toxoplasma gondii in sera, intestinal secretions, and milk from orally infected mice and characterization of target antigens , 1990, Infection and immunity.

[25]  T. Nagamine,et al.  Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite pre-existing immunity to CTB. , 1989, Vaccine.

[26]  L. Kasper,et al.  Purification of a major membrane protein of Toxoplasma gondii by immunoabsorption with a monoclonal antibody. , 1983, Journal of immunology.